103 related articles for article (PubMed ID: 9135493)
1. Recombinant tumour necrosis factor in the local therapy of malignant pleural effusion.
Rauthe G; Sistermanns J
Eur J Cancer; 1997 Feb; 33(2):226-31. PubMed ID: 9135493
[TBL] [Abstract][Full Text] [Related]
2. Pleurodesis with recombinant tumour necrosis factor in gynaecological neoplasms.
Rauthe G; Sistermanns J
Eur J Gynaecol Oncol; 1998; 19(2):108-12. PubMed ID: 9611046
[TBL] [Abstract][Full Text] [Related]
3. Interferon instillation for malignant pleural effusions.
Goldman CA; Skinnider LF; Maksymiuk AW
Ann Oncol; 1993 Feb; 4(2):141-5. PubMed ID: 8448082
[TBL] [Abstract][Full Text] [Related]
4. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
5. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy.
Seaton KG; Patz EF; Goodman PC
AJR Am J Roentgenol; 1995 Mar; 164(3):589-91. PubMed ID: 7532350
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
7. The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions.
Habal P; Jankovicova K; Omran N; Kondelkova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):311-5. PubMed ID: 23235721
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion.
Hsu WH; Chiang CD; Chen CY; Kwan PC; Hsu JY
Jpn J Clin Oncol; 1998 Mar; 28(3):187-91. PubMed ID: 9614441
[TBL] [Abstract][Full Text] [Related]
9. Streptokinase for malignant pleural effusions: a randomized controlled study.
Okur E; Baysungur V; Tezel C; Ergene G; Okur HK; Halezeroglu S
Asian Cardiovasc Thorac Ann; 2011 Jun; 19(3-4):238-43. PubMed ID: 21885549
[TBL] [Abstract][Full Text] [Related]
10. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
11. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.
Prevost A; Nazeyrollas P; Milosevic D; Fernandez-Valoni A
Oncol Rep; 1998; 5(2):363-6. PubMed ID: 9468558
[TBL] [Abstract][Full Text] [Related]
13. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients.
Arapis K; Caliandro R; Stern JB; Girard P; Debrosse D; Gossot D
Surg Endosc; 2006 Jun; 20(6):919-23. PubMed ID: 16738983
[TBL] [Abstract][Full Text] [Related]
14. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions.
Sahin U; Unlü M; Akkaya A; Ornek Z
Respiration; 2001; 68(5):501-5. PubMed ID: 11694813
[TBL] [Abstract][Full Text] [Related]
15. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
16. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
17. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
18. Recombinant interferon alpha-2b in the management of malignant pleural effusions.
Wilkins HE; Connolly MM; Grays P; Marquez G; Nelson D
Chest; 1997 Jun; 111(6):1597-9. PubMed ID: 9187180
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha and nitric oxide, determined as nitrite, in malignant pleural effusion.
Agrenius V; Gustafsson LE; Widström O
Respir Med; 1994 Nov; 88(10):743-8. PubMed ID: 7846335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
